{
  "nct_id": "NCT12345678",
  "title": "Phase 2 Study of Test Drug in Breast Cancer",
  "status": "Recruiting",
  "phases": ["Phase 2"],
  "conditions": ["Breast Cancer", "HER2 Positive Breast Cancer"],
  "eligibility": {
    "criteria": "Inclusion Criteria:\n- Age >= 18 years\n- Histologically confirmed breast cancer\n- HER2 positive disease\n- ECOG performance status 0-1\n\nExclusion Criteria:\n- Prior chemotherapy for metastatic disease\n- Brain metastases\n- Active infection"
  },
  "interventions": [
    {
      "type": "Drug",
      "name": "Test Drug",
      "description": "Experimental targeted therapy"
    }
  ],
  "locations": [
    {
      "facility": "Test Hospital",
      "city": "Test City",
      "state": "Test State",
      "country": "United States"
    }
  ]
}